Cancer Vaccines in Ovarian Cancer: How Can We Improve?

por Martin Lluesma, Silvia, Wolfer, Anita, Harari, Alexandre, Kandalaft, Lana E.
Publicado 2016

Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?

por Martin Lluesma, Silvia, Graciotti, Michele, Chiang, Cheryl Lai-Lai, Kandalaft, Lana E.
Publicado 2018

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity

por Tsoutsou, Pelagia G., Zaman, Khalil, Martin Lluesma, Silvia, Cagnon, Laurene, Kandalaft, Lana, Vozenin, Marie-Catherine
Publicado 2018

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade o...

por Sarivalasis, Apostolos, Boudousquié, Caroline, Balint, Klara, Stevenson, Brian J., Gannon, Philippe O., Iancu, Emanuela Marina, Rossier, Laetitia, Martin Lluesma, Silvia, Mathevet, Patrice, Sempoux, Christine, Coukos, George, Dafni, Urania, Harari, Alexandre, Bassani-Sternberg, Michal, Kandalaft, Lana E.
Publicado 2019

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancre...

por Bassani-Sternberg, Michal, Digklia, Antonia, Huber, Florian, Wagner, Dorothea, Sempoux, Christine, Stevenson, Brian J., Thierry, Anne-Christine, Michaux, Justine, Pak, HuiSong, Racle, Julien, Boudousquie, Caroline, Balint, Klara, Coukos, George, Gfeller, David, Martin Lluesma, Silvia, Harari, Alexandre, Demartines, Nicolas, Kandalaft, Lana E.
Publicado 2019